Stifel Maintains Buy on Exact Sciences, Lowers Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Daniel Arias maintains a Buy rating on Exact Sciences (NASDAQ:EXAS) but lowers the price target from $100 to $82.
August 01, 2024 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stifel analyst Daniel Arias maintains a Buy rating on Exact Sciences but lowers the price target from $100 to $82.
The Buy rating suggests continued confidence in the company's long-term prospects, but the lowered price target indicates some short-term concerns or adjustments in valuation. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100